Review Article: Nonclinical and Clinical Pharmacology, Pharmacokinetics and Pharmacodynamics of Etrolizumab, an Anti-Β7 Integrin Therapy for Inflammatory Bowel Disease
Alimentary Pharmacology and Therapeutics - United Kingdom
doi 10.1111/apt.14631
Full Text
Open PDFAbstract
Available in full text
Date
March 30, 2018
Authors
Publisher
Wiley